North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

You are here: Home Catalog Pharma & Healthcare Pharmaceutical Manufacturing Drug Delivery

North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

Market Research Report Summary

North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity report is published on December 29, 2020 and has 106 pages in it. This 91制片厂 report provides information about Pharmaceutical Manufacturing, Drug Delivery, Pharma & Healthcare industry. It covers North America market data and forecasts. It is priced starting at USD 2,800.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized 91制片厂 report to meet your research goals and data requirements.

North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

Printer version

Send by email

Publication ID:听

GRM1220018

Publication Date:听

December 29, 2020

笔补驳别蝉:听

106

笔耻产濒颈蝉丑别谤:听

Grace Market Data

颁辞耻苍迟谤颈别蝉:听

North America

USD 2,800.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their 91制片厂 needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

North America pharmaceutical CRO market is expected to grow by 7.3% annually in the forecast period and reach $37.61 billion by 2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 26 tables and 41 figures, this 106-page report 鈥淣orth America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire North America pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� Market Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & Market Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
鈥� CRO for Pre-clinical Development
鈥� CRO for Phase I Trials
鈥� CRO for Phase II Trials
鈥� CRO for Phase III Trials
鈥� CRO for Phase IV Trials
鈥� Laboratory Services
鈥� Consulting Services
鈥� Data Management Services

Based on Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
鈥� Infectious Diseases
鈥� Oncology
鈥� Metabolic Disorders
鈥� Cardiovascular Disorders
鈥� Central Nervous System
鈥� Respiratory Disorders
鈥� Gastrointestinal Disorders
鈥� Other Therapeutic Applications

Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
鈥� Pharmaceutical & Biopharmaceutical Companies
鈥� Medical Device Companies
鈥� Academic Institutes

Geographically, the following national/local markets are fully investigated:
鈥� U.S.
鈥� Canada
鈥� Mexico
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America pharmaceutical CRO market are assayed quantitatively and qualitatively through GMD鈥檚 Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co Ltd
ICON Plc
IQVIA Holdings Inc.
LSK North America Pharma Service Co Ltd
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co. Ltd
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

Table of Contents
1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter鈥檚 Fiver Forces Analysis 37
3 Segmentation of North America Market by Service 41
3.1 Market Overview by Service 41
3.2 CRO for Pre-clinical Development 43
3.3 CRO for Phase I Trials 44
3.4 CRO for Phase II Trials 45
3.5 CRO for Phase III Trials 46
3.6 CRO for Phase IV Trials 47
3.7 Laboratory Services 48
3.8 Consulting Services 49
3.9 Data Management Services 50
4 Segmentation of North America Market by Therapeutic Application 51
4.1 Market Overview by Therapeutic Application 51
4.2 Infectious Diseases 53
4.3 Oncology 54
4.4 Metabolic Disorders 55
4.5 Cardiovascular Disorders 56
4.6 Central Nervous System 57
4.7 Respiratory Disorders 58
4.8 Gastrointestinal Disorders 59
4.9 Other Therapeutic Applications 60
5 Segmentation of North America Market by End User 61
5.1 Market Overview by End User 61
5.2 Pharmaceutical & Biopharmaceutical Companies 63
5.3 Medical Device Companies 64
5.4 Academic Institutes 65
6 North America Market 2019-2030 by Country 67
6.1 Overview of North America Market 67
6.2 U.S. 70
6.3 Canada 74
6.4 Mexico 76
7 Competitive Landscape 78
7.1 Overview of Key Vendors 78
7.2 New Product Launch, Partnership, Investment, and M&A 82
7.3 Company Profiles 83
Charles River Laboratories 83
CMIC Co. Ltd 85
Covance Inc. 86
Hangzhou Tigermed Consulting Co Ltd 87
ICON Plc 88
IQVIA Holdings Inc. 89
LSK North America Pharma Service Co Ltd 90
Novotech Pty Ltd 91
PAREXEL International Corporation 92
Pharmaceutical Product Development LLC (PPD) 93
PRA Health Sciences Inc. 94
Quanticate Ltd 95
Samsung Bioepis Co. Ltd 96
SGS SA (SGS Life Sciences) 97
Syneos Health Inc. 98
WuXi AppTec Inc. 99
8 Investing in North America Market: Risk Assessment and Management 100
8.1 Risk Evaluation of North America Market 100
8.2 Critical Success Factors (CSFs) 103
Related Reports and Products 106

Companies Covered

Key Players (this may not be a complete list and extra companies can be added upon request):
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co Ltd
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co Ltd
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co. Ltd
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this 91制片厂 report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Pharmaceutical Manufacturing

Drug Delivery

Pharma & Healthcare

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related Market Research Reports

Publication	Price
Global Hirudin-based Drugs Market Growth (Status and Outlook) 2025-2031 According to this study, the global Hirudin-based Drugs market size will reach US$ 5056 million by 2031. Hirudin is a natural anticoagulant protein initially extracted from leeches, known for its powerful blood-thinning properties. It works by directly binding to thrombin, inhibiting its activity, and thus effectively preventing blood coagulation. Over time, the production of hirudin has transitioned from natural extraction to recombinant DNA technology, significantly improving production efficiency, safety, and product consistency. Common hirudin-based products include Lepirudin (Refludan) and Desirudin (Iprivask), which are primarily used in the treatment and prevention of thrombotic diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), and thrombus-related cardiovascular conditions. Hirudin products are particularly suitable for patients who cannot use traditional anticoagulants, such as those with heparin-induced thrombocytopenia (HIT). These products have...Read more	USD 3,660.00
Global Chinese Medicine Injection for Respiratory System Market Growth 2025-2031 The global Chinese Medicine Injection for Respiratory System market size is predicted to grow from US$ 1316 million in 2025 to US$ 1663 million in 2031; it is expected to grow at a CAGR of 4.0% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Chinese Medicine Injections for the Respiratory System are injectable formulations developed from traditional herbal remedies aimed at treating respiratory conditions such as infections, cough, asthma, and pulmonary inflammation. These injections typically offer functions like clearing heat and toxins, relieving cough and asthma, and resolving phlegm and dampness. They are often used as adjunctive therapies in acute respiratory cases, particularly within integrated traditional and modern medical approaches. While...Read more	USD 3,660.00
Global CXO Services Market Growth (Status and Outlook) 2025-2031 According to this study, the global CXO Services market size will reach US$ 161583 million by 2031. CXO Services refer to a broad category of outsourced services provided to pharmaceutical, biotechnology, and life sciences companies to support the development, manufacturing, and commercialization of drugs and therapeutics. The term "CXO" collectively represents contract-based services, in this report, CXO include CRO and CDMO. United States market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key CXO Services players cover Lonza, Catalent, Samsung Biologics, FUJIFILM...Read more	USD 3,660.00
Global Blood Lipid Control Products Market Growth 2025-2031 The global Blood Lipid Control Products market size is predicted to grow from US$ 151 million in 2025 to US$ 183 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Blood lipid control products are standard reference materials used for quality control of blood lipid items (such as cholesterol and triglycerides) in clinical tests. They are usually made from processed serum and have clear target values 鈥嬧€媋nd stability. They can be used to monitor and evaluate the performance of testing instruments and reagents to ensure the accuracy and consistency of test results. They are an indispensable and important part of the laboratory quality management system. United States market for Blood Lipid...Read more	USD 3,660.00
Global Chinese Medicine Injection for Nervous Diseases Market Growth 2025-2031 The global Chinese Medicine Injection for Nervous Diseases market size is predicted to grow from US$ 2008 million in 2025 to US$ 2467 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Chinese medicine injections for nervous system diseases are formulations that combine traditional Chinese medicine principles with modern pharmaceutical technology, primarily used to treat cerebrovascular diseases, neurodegenerative disorders, and neuropathic pain. Administered intravenously or intramuscularly, these injections bypass the gastrointestinal tract, enhancing bioavailability and providing rapid therapeutic effects, making them suitable for acute and severe cases. Common examples include XingNaoJing...Read more	USD 3,660.00

Clients Who Trust Us

Need tailor made 91制片厂 solution? We can help you with that too.

Contact Us

About Us

At 91制片厂. we aim to make it easier for decision makers to find relevant information and locate right 91制片厂 reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global 91制片厂 firms who are known leaders in their respective domains to obtain right 91制片厂 solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

91制片厂
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 91制片厂. has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom 91制片厂 from our website MarketResearchReports.com only.

If you are looking for a 91制片厂 solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our 91制片厂 consultants or directly write to us.

91制片厂